JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M610253200 on February 6, 2007

J. Biol. Chem., Vol. 282, Issue 13, 9526-9535, March 30, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/13/9526    most recent
M610253200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lloyd-Burton, S. M.
Right arrow Articles by Schell, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lloyd-Burton, S. M.
Right arrow Articles by Schell, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of Inositol 1,4,5-Trisphosphate 3-Kinases by Calcium and Localization in Cells*

Samantha M. Lloyd-Burton{ddagger}1, Jowie C. H. Yu{ddagger}2, Robin F. Irvine{ddagger}3, and Michael J. Schell§4

From the {ddagger}Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom and the §Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814

Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) 3-kinases (IP3Ks) are a group of calmodulin-regulated inositol polyphosphate kinases (IPKs) that convert the second messenger Ins(1,4,5)P3 into inositol 1,3,4,5-tetrakisphosphate. However, what they contribute to the complexities of Ca2+ signaling, and how, is still not fully understood. In this study, we have used a simple Ca2+ imaging assay to compare the abilities of various Ins (1,4,5)P3-metabolizing enzymes to regulate a maximal histamine-stimulated Ca2+ signal in HeLa cells. Using transient transfection, we overexpressed green fluorescent protein-tagged versions of all three mammalian IP3K isoforms, including mutants with disrupted cellular localization or calmodulin regulation, and then imaged the Ca2+ release stimulated by 100 µM histamine. Both localization to the F-actin cytoskeleton and calmodulin regulation enhance the efficiency of mammalian IP3Ks to dampen the Ins (1,4,5)P3-mediated Ca2+ signals. We also compared the effects of the these IP3Ks with other enzymes that metabolize Ins(1,4,5)P3, including the Type I Ins(1,4,5)P3 5-phosphatase, in both membrane-targeted and soluble forms, the human inositol polyphosphate multikinase, and the two isoforms of IP3K found in Drosophila. All reduce the Ca2+ signal but to varying degrees. We demonstrate that the activity of only one of two IP3K isoforms from Drosophila is positively regulated by calmodulin and that neither isoform associates with the cytoskeleton. Together the data suggest that IP3Ks evolved to regulate kinetic and spatial aspects of Ins (1,4,5)P3 signals in increasingly complex ways in vertebrates, consistent with their probable roles in the regulation of higher brain and immune function.


Received for publication, November 2, 2006 , and in revised form, January 11, 2007.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by a Studentship from Merck Sharp & Dohme.

2 Supported by the Croucher Foundation.

4 Supported by the Case Fellowship from the Royal Society and by Uniformed Services University of the Health Sciences Grant RO75LN.

3 Supported by the Royal Society and the Wellcome Trust. To whom correspondence should be addressed: Dept. of Pharmacology, University of Cambridge, Tennis Ct. Rd., Cambridge CB2 1PD, United Kingdom. Tel.: 44-1223-339683; Fax: 44-1223-334040; E-mail: rfi20{at}cam.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.